Related Experiment Video
Updated: Sep 14, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Familial hypercholesterolemia in Sri Lanka: Addressing evidence gaps and paving the road ahead
1Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Abstract:
In recent years, South Asia has witnessed a staggering increase in the rate of cardiovascular (CV) deaths, overburdening healthcare systems in this low- to middle-income region. Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Identifying potential gaps in screening and managing dyslipidemia could help to develop a framework for CVD management in this region. Among dyslipidemias, familial hypercholesterolemia (FH) is a risk factor for premature CVD. Data on FH in Sri Lanka, a South Asian country, are sparse. This report is the first to identify and address problems associated with FH in Sri Lanka. It provides insight into the practices employed within the country and helps assess potential barriers in managing patients with FH.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures

